SecBot SecBot
PRESS-RELEASE ·Filed Sep 22, 2026

INNV

InnovAge
BEARISH
Impact 5/10
Horizondays Processed1mo ago WireGlobeNewswire
Press release · Offering
Actionable Insight ▼ Bearish

Monitor the stock for continued selling pressure as the secondary clears. The $9.25 pricing below the prior close suggests underwriters needed a discount to move the block. Watch for any insider buying post-offering as a signal of management confidence.

DirectionBearish
Confidencehigh
Horizondays
Latest settled: T+20d ⚠ clustered
INNV ▲ +1.56% at T+20d
SHORT call ✗ call lost -1.56% · α vs SPY -0.87% · entry $9.00 → $9.14
Next anchor: T+60d in 7w
Latest observation: T+22 -10.47% FF3 residual α
Entry = T+0 close
Sep 22, 2026
via day close
T+1d
-1.78%
call +1.78% · α +1.70%
$8.84
settled 5w ago
T+5d
-2.22%
call +2.22% · α +1.55%
$8.80
settled 29d ago
T+20d
+1.56%
call -1.56% · α -0.87%
$9.14
settled 8d ago
T+60d
Pending
in 7w

Price Chart

Loading chart...

Executive Summary

Apax Partners and Welsh Carson are selling 10M shares of InnovAge common stock at $9.25/share in an underwritten secondary offering. InnovAge receives no proceeds, so the event is a pure overhang removal for existing holders but signals insider monetization at a price below the last close.

Key Financial Metrics

Deal Value
$92.5M

Key Facts

  • Secondary offering of 10,000,000 shares by Apax Partners and Welsh Carson at $9.25/share
  • Underwriters have a 30-day option for an additional 1,500,000 shares
  • InnovAge receives no proceeds; selling stockholders get all proceeds
  • Offering expected to close September 24, 2026
  • Barclays, Goldman Sachs, and Wells Fargo are lead book-runners

Financial Impact

10M shares sold at $9.25/share = $92.5M total offering; additional 1.5M shares option = $13.875M if exercised. No proceeds to InnovAge.

dilutionshare price

Risk Factors

  • Insider monetization by major holders may signal lack of confidence in near-term upside
  • Additional 1.5M shares overhang if underwriters exercise the greenshoe option
  • No capital raised for the company — purely a liquidity event for selling stockholders

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 1 press release from GlobeNewswire.

DocumentAccession Number
PRESS-RELEASE Data (Synthetic)press-3367052
13 reports for INNV
Performance horizon
80% Hit rate @ T+1 4 of 5 directional calls Went positive at some point 4 of 5 best @ T+5▲ +2.22%Sep 22, 2026
Filters
Rows
Reports for INNV, sortable and filterable
TypeNow
Oct 26, 2026
1d ago
Insider Cluster
BEARISH ★ 6/10
$9.27awaiting T+1awaiting T+1$9.12 (+1.62%)
Oct 23, 2026
4d ago
Insider Cluster
BEARISH ★ 7/10
$9.27 $9.12▲ +1.62%▲ +2.18%$9.12 (+1.62%)
Oct 23, 2026
4d ago
Insider Cluster
BEARISH ★ 7/10
$9.27 $9.12▲ +1.62%▲ +2.18%$9.12 (+1.62%)
Oct 22, 2026
5d ago
DEFA14A
NEUTRAL ★ 2/10
$9.55 $9.27▼ −2.93%▼ −3.64%$9.12 (−4.50%)
Oct 22, 2026
5d ago
DEF 14A
NEUTRAL ★ 3/10
$9.55 $9.27▼ −2.93%▼ −3.64%$9.12 (−4.50%)
Sep 29, 2026
29d ago
Insider Cluster
BEARISH ★ 7/10
$8.80 $8.80· 0.00%▲ +0.18%$9.12 (−3.64%)
Sep 28, 2026
4w ago
Insider Cluster
BEARISH ★ 7/10
$8.98 $8.80▲ +2.00%▲ +1.80%$9.12 (−1.56%)
Sep 22, 2026
5w ago
Press Release
BEARISH ★ 5/10
$9.00 $8.84▲ +1.78%▲ +1.70%$9.12 (−1.33%)
Sep 22, 2026
5w ago
Press Release
BEARISH ★ 6/10
$9.00 $8.84▲ +1.78%▲ +1.70%$9.12 (−1.33%)
Aug 26, 2026
8w ago
Press Release
NEUTRAL ★ 1/10
$11.04awaiting T+1awaiting T+1$9.12 (−17.39%)
Showing 10 of 13

US Market Status

Market Closed · Opens in 4h 32m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 22, 2026